Sex and gender considerations in clinical trials for Alzheimer's disease: current state and recommendations

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F21%3A10429938" target="_blank" >RIV/00064203:_____/21:10429938 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11130/21:10429938

Result on the web

<a href="https://doi.org/10.1016/B978-0-12-819344-0.00017-X" target="_blank" >https://doi.org/10.1016/B978-0-12-819344-0.00017-X</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/B978-0-12-819344-0.00017-X" target="_blank" >10.1016/B978-0-12-819344-0.00017-X</a>

Result language

angličtina

Original language name

Sex and gender considerations in clinical trials for Alzheimer's disease: current state and recommendations

Original language description

This chapter describes the current situation regarding sex and gender considerations in clinical trials from preclinical research in animal models to large efficacy trials. Despite women comprise two-thirds of the AD population, for several reasons discussed in this chapter such as eligibility criteria or sociocultural factors, women are underrepresented in clinical trials. We provide a set of recommendations that should help revert this situation.

Czech name

—

Czech description

—

Type

C - Chapter in a specialist book

CEP classification

—

OECD FORD branch

30103 - Neurosciences (including psychophysiology)

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2021

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Book/collection name

Sex and Gender Differences in Alzheimer&apos;s Disease

ISBN

978-0-12-819344-0

Number of pages of the result

19

Pages from-to

309-327

Number of pages of the book

477

Publisher name

Elsevier

Place of publication

Londýn

UT code for WoS chapter

—